The case, involving a supplement intended to reduce cholesterol, has put attention on how companies are allowed to self-report claims about their products.The case, involving a supplement intended to reduce cholesterol, has put attention on how companies are allowed to self-report claims about their products. Drugs (Pharmaceuticals), Dietary Supplements and Herbal Remedies, Regulation and Deregulation of Industry, Medicine and Health, Cholesterol, Japan Read More
